Correlation Between Aarey Drugs and COSMO FIRST
Specify exactly 2 symbols:
By analyzing existing cross correlation between Aarey Drugs Pharmaceuticals and COSMO FIRST LIMITED, you can compare the effects of market volatilities on Aarey Drugs and COSMO FIRST and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aarey Drugs with a short position of COSMO FIRST. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aarey Drugs and COSMO FIRST.
Diversification Opportunities for Aarey Drugs and COSMO FIRST
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Aarey and COSMO is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Aarey Drugs Pharmaceuticals and COSMO FIRST LIMITED in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSMO FIRST LIMITED and Aarey Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aarey Drugs Pharmaceuticals are associated (or correlated) with COSMO FIRST. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSMO FIRST LIMITED has no effect on the direction of Aarey Drugs i.e., Aarey Drugs and COSMO FIRST go up and down completely randomly.
Pair Corralation between Aarey Drugs and COSMO FIRST
Assuming the 90 days trading horizon Aarey Drugs Pharmaceuticals is expected to generate 0.67 times more return on investment than COSMO FIRST. However, Aarey Drugs Pharmaceuticals is 1.48 times less risky than COSMO FIRST. It trades about -0.36 of its potential returns per unit of risk. COSMO FIRST LIMITED is currently generating about -0.32 per unit of risk. If you would invest 5,961 in Aarey Drugs Pharmaceuticals on November 4, 2024 and sell it today you would lose (1,066) from holding Aarey Drugs Pharmaceuticals or give up 17.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aarey Drugs Pharmaceuticals vs. COSMO FIRST LIMITED
Performance |
| Timeline |
| Aarey Drugs Pharmace |
| COSMO FIRST LIMITED |
Aarey Drugs and COSMO FIRST Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aarey Drugs and COSMO FIRST
The main advantage of trading using opposite Aarey Drugs and COSMO FIRST positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aarey Drugs position performs unexpectedly, COSMO FIRST can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSMO FIRST will offset losses from the drop in COSMO FIRST's long position.| Aarey Drugs vs. MEDI ASSIST HEALTHCARE | Aarey Drugs vs. Entero Healthcare Solutions | Aarey Drugs vs. 21st Century Management | Aarey Drugs vs. Salzer Electronics Limited |
| COSMO FIRST vs. The Investment Trust | COSMO FIRST vs. Dev Information Technology | COSMO FIRST vs. Tata Investment | COSMO FIRST vs. Computer Age Management |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |